News from benitec biopharma limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 06, 2019, 08:09 ET Update on Oculopharyngeal Muscular Dystrophy Program

Benitec Biopharma Limited ("Benitec" or the "Company") (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announced the termination of the License and...


Sep 19, 2018, 08:00 ET Benitec Biopharma Announces the Appointment of Gregory R. Reyes, M.D., Ph.D. as Senior Scientific Advisor

Benitec Biopharma Limited ("Benitec" or the "Company") (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW), a clinical-stage biotechnology company developing...


May 31, 2018, 08:00 ET Benitec Biopharma reports financial results for the 2018 fiscal third quarter and provides operational update

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) ("Benitec" or "the Company"), a biotechnology company developing innovative...


May 15, 2018, 08:00 ET Benitec to present OPMD data at the American Society of Gene and Cell Therapy Meeting

Benitec Biopharma Limited (ASX:BLT; NASDAQ:BNTC; NASDAQ:BNTCW) today announced that data from its oculopharyngeal muscular dystrophy (OPMD) program...


May 03, 2018, 08:00 ET Benitec to Host Investor Webinar on the Company's Oculopharyngeal Muscular Dystrophy (OPMD) Program

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announced that it will host a conference call and webcast for investors and...


Apr 24, 2018, 08:00 ET ASX/NASDAQ Announcement

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today provided an update on its two lead programs in head and neck squamous cell...


Mar 05, 2018, 08:00 ET Benitec Biopharma Launches its Phase 2 Oncology Study in Australia

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) ("Benitec" or "the Company"), a biotechnology company developing innovative...


Feb 22, 2018, 08:30 ET Benitec Biopharma reports financial results for the 2018 fiscal second quarter and provides operational update

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) ("Benitec" or "the Company"), a biotechnology company developing innovative...


Jan 23, 2018, 04:17 ET Federal R&D Tax Credit Received

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) advises that it has received a $4,112,058 cash refund for the year ended 2017 under ...


Jan 16, 2018, 08:00 ET Benitec receives U.S. Orphan Drug Designation for BB-301, its ddRNAi therapeutic for the treatment of oculopharyngeal muscular dystrophy

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announced that the U.S. Food & Drug Administration (FDA) has granted Orphan...


Nov 27, 2017, 07:00 ET Benitec Biopharma provides update on OPMD orphan disease program

Benitec Biopharma Limited (ASX:BLT; NASDAQ:BNTC; NASDAQ:BNTCW) is pleased to announce it has submitted an application with the U.S. Food & Drug...


Oct 18, 2017, 07:45 ET U.S. patent granted for Benitec hepatitis B program

Benitec Biopharma Limited (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce that a new patent relating to the Company's hepatitis B...


Aug 08, 2017, 08:30 ET Benitec Biopharma advances OPMD orphan disease program

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce it has developed a new single vector (gene therapy...


Apr 04, 2017, 08:00 ET Key pre-clinical data on oculopharyngeal muscular dystrophy (OPMD) published in Nature Communications

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce that the initial pre-clinical efficacy results of the OPMD...


Mar 13, 2017, 06:00 ET Benitec Biopharma completes second tranche placement to Nant Capital to raise A$5.45 million

Benitec Biopharma Limited (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW) (Benitec) today announced that in accordance with the Share Subscription Agreement...


Feb 16, 2017, 07:00 ET Benitec Biopharma to present expanded data set from pivotal data in hepatitis B virus (HBV) in vivo model at International Liver Meeting in Shanghai, China

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announced that it will present pivotal data from the Company's hepatitis B...


Feb 02, 2017, 06:00 ET Benitec Biopharma makes significant progress in ocular program

Benitec Biopharma Limited (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce today that it has made significant progress with the...


Jan 30, 2017, 07:00 ET Benitec initiates development work on head and neck cancer programs after executing Collaboration Agreement with Nant Capital

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce that it has initiated work on two new oncology pipeline...


Jan 17, 2017, 04:00 ET Benitec Receives Orphan Drug Designation in the European Union for BB-301, a ddRNAi Therapeutic in Development for the Treatment of Oculopharyngeal Muscular Dystrophy

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce that the European Commission, based on a favourable...


Dec 23, 2016, 06:00 ET Benitec in-licenses clinical program for head and neck cancer from NantWorks

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announced that it has executed an exclusive, world-wide sublicensing...


Dec 20, 2016, 07:00 ET Benitec releases pivotal data in an in vivo hepatitis B model

Benitec Biopharma Limited (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announced significant progress on use of the company's technology for...


Oct 24, 2016, 07:10 ET Benitec initiates a strategic engagement with NantVentures

Benitec Biopharma Limited (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW) ("Benitec") announces that it has commenced a strategic engagement with NantVentures....


Aug 10, 2016, 05:00 ET Benitec announces restructuring of Senior Executive team

Key points: Mr Greg West appointed permanent CEO Dr Cliff Holloway appointed CBO and COO Mr Bryan Dulhunty appointed CFO Management team strengthened ...


May 17, 2016, 05:00 ET Benitec Biopharma to Host Corporate Update Conference Call

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announced that the Company will host a conference call and live audio webcast ...


Apr 25, 2016, 08:30 ET Benitec to present at the ASGCT 2016 Annual Meeting

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW), a biotechnology company developing innovative therapeutics based on its patented...